Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Mereo BioPharma Group (MREO) Shares Outstanding (Diluted Average): 2023-2024

Historic Shares Outstanding (Diluted Average) for Mereo BioPharma Group (MREO) over the last 2 years, with Dec 2024 value amounting to $739.6 million.

  • Mereo BioPharma Group's Shares Outstanding (Diluted Average) rose 3.87% to $799.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $799.9 million, marking a year-over-year increase of 3.87%. This contributed to the annual value of $739.6 million for FY2024, which is 12.16% up from last year.
  • Per Mereo BioPharma Group's latest filing, its Shares Outstanding (Diluted Average) stood at $739.6 million for FY2024, which was up 12.16% from $659.5 million recorded in FY2023.
  • In the past 5 years, Mereo BioPharma Group's Shares Outstanding (Diluted Average) ranged from a high of $739.6 million in FY2024 and a low of $659.5 million during FY2023.
  • Over the past 2 years, Mereo BioPharma Group's median Shares Outstanding (Diluted Average) value was $699.5 million (recorded in 2023), while the average stood at $699.5 million.
  • Data for Mereo BioPharma Group's Shares Outstanding (Diluted Average) shows a peak YoY rose of 12.16% (in 2024) over the last 5 years.
  • Over the past 2 years, Mereo BioPharma Group's Shares Outstanding (Diluted Average) (Yearly) stood at $659.5 million in 2023, then increased by 12.16% to $739.6 million in 2024.